Guneet Kaleka, MD MPA

Hematology/Oncology Fellow, Division of Hematology and Oncology
University of California Davis School of Medicine

Poster(s):

• (PA-401) Intensified Cyclophosphamide, Bortezomib, Dexamethasone (iCyBorD) for the treatment of newly diagnosed Multiple Myeloma with Acute Kidney Injury
  Friday, September 19, 2025